Financial modeling of current surgical robotic system in outpatient laparoscopic cholecystectomy: how should we think about the expense?
BACKGROUND
More than 500,000 robotically assisted procedures were performed worldwide in 2013. Despite broad adoption, there remains a lack of clarity concerning the added cost of the robotic system to the procedure especially in light of an increasing number of ambulatory procedures which are now marketed by hospitals, surgeons and the manufacturer. These procedures are associated with much less reimbursement than inpatient procedures. It is unclear whether these added expenses can be absorbed in these scenarios. Reports vary in opinion concerning the added net costs during robotically assisted laparoscopic hernia or cholecystectomy.


METHODS
The worldwide revenues, procedures, and the installed base of robotic system data were reviewed and reanalyzed from the 2013 Intuitive Surgical Investors report. This provided an opportunity to look cost per case projections from the vantage point of actual revenue.


RESULTS
This analysis was based on revenue of 2.27 billion US dollars in the three categories of capital acquisition, instrumentation and accessories, and service revenue. These revenues were then spread across 523,000 cases with varying assumptions. Without regard to expense offsets, the additional cost ranges from $2908 to $8675 depending on what system was purchased and the ability to distribute costs against case volume. Estimates of commercial and government revenue were then compared against these expenses.


CONCLUSIONS
The use of the extraordinary technology in the face of low-morbidity low-cost established minimally invasive procedures needs to withstand scrutiny of outcome assessment, revenue and expense considerations and appropriateness review in order to create financially viable approaches to high-volume minimally invasive procedures. Revenue estimates associated with outpatient reimbursement make it difficult to support these expenses, recognizing inpatient procedures represent a different net financial picture.
Cambridge Health Alliance, Cambridge, MA, USA. sschwaitzberg@challiance.org.|Harvard Medical School, Boston, MA, USA. sschwaitzberg@challiance.org.
S D
SD
Schwaitzberg
D000556:Ambulatory Surgical Procedures / Q000191:economics*; D017081:Cholecystectomy, Laparoscopic / Q000191:economics*; D003365:Costs and Cost Analysis; D006801:Humans; D010535:Laparoscopy / Q000191:economics*; D018803:Models, Economic; D012051:Reimbursement Mechanisms; D065287:Robotic Surgical Procedures / Q000191:economics*; D014481:United States
Outpatient surgery; Procedural expense; Procedural revenue; Robot; Surgical robot